Clinical Trials in Michigan

Showing 8861-8880 of 12,290 trials

Clinical Evaluation of Patients With X-linked Retinoschisis

NCT02331173

The purpose of this study is to evaluate subjects with X-linked retinoschisis in a clinical setting to collect data on disease progression.

X-linked RetinoschisisXLRS

Beacon Therapeutics66 participantsStarted Nov 2012

Ann Arbor, Michigan, United States • Portland, Oregon, United States • Dallas, Texas, United States

COMPLETEDNA83 miles

Effectiveness of the Optifast Program Compared With a Reduced-energy Food Based Diet Plan on Body Weight

NCT02635698

Compare percent change in loss of body weight between the OPTIFAST program and a food-based energy-deficit program

Obesity

Société des Produits Nestlé (SPN)330 participantsStarted Nov 2015

Anchorage, Alaska, United States • Schaumburg, Illinois, United States • Ann Arbor, Michigan, United States +6 more locations

COMPLETEDPhase 389 miles

Randomized Switch Study From Hydroxyurea to Ruxolitinib for RELIEF of Polycythemia Vera Symptoms: The Relief Study

NCT01632904

The purpose of the RELIEF study is to compare symptoms in polycythemia vera (PV) subjects treated with ruxolitinib versus subjects treated with hydroxyurea (HU) as measured by the percent of subjects who achieve a clinically meaningful symptom improvement (ie, total symptom score reduction of ≥ 50% reduction) at Week 16 compared to Baseline. The study is also designed to demonstrate that these responses are durable with continued treatment.

Polycythemia Vera

Incyte Corporation110 participantsStarted Jun 2012

Scottsdale, Arizona, United States • Fayetteville, Arkansas, United States • Burbank, California, United States +67 more locations

Clinical Evaluation of Patients With X-linked Retinoschisis

Effectiveness of the Optifast Program Compared With a Reduced-energy Food Based Diet Plan on Body Weight

Randomized Switch Study From Hydroxyurea to Ruxolitinib for RELIEF of Polycythemia Vera Symptoms: The Relief Study

Find Trials by Condition in Michigan

TRX4 Monoclonal Antibody in Type 1 Diabetes (T1 DM)

Single Dose Intravesical Apaziquone Postoperative in Patients Undergoing TURBT for Noninvasive Bladder Cancer (SPI-612)

VEG111485: A QTc Study of Pazopanib

A Pharmacokinetics Study of the Effects of GSK2118436 on Warfarin, the Effects of Ketoconazole and Gemfibrozil on GSK2118436, and the Effects of Repeat Doses of GSK2118436 in Subjects With BRAF Mutant Solid Tumors

A Dose-Finding Study of GSK2894512 Cream in Subjects With Plaque Psoriasis

Proof of Concept (POC) in Patients With Ischaemic Stroke

Pharmacokinetics And Pharmacodynamics Of Lapatinib In Two Dosing Regimens In Treatment-naive Patients With Breast Cancer

Extended Follow-Up After Islet Transplantation in T1D

Randomized, Placebo Controlled Study Of The Efficacy And Safety Of PF-02545920 In Subjects With Huntington's Disease

Natural Evolution of AV Conduction Disorders in Patients Implanted With Cardiac Pacemakers

Evaluating the Efficacy and Safety of Fluticasone Furoate Inhalation Powder in the Treatment of Asthma in Adults and Adolescents

Immunogenicity and Safety Study of Different Formulations of GlaxoSmithKline (GSK) Biologicals H7N1 Influenza Vaccine Administered to Adults 65 Years of Age and Older

Study Of SB-497115 in Healthy Subjects and Subjects With Mild, Moderate or Severe Renal Impairment

A Phase IIIb Study to Evaluate the Efficacy of Umeclidinium/Vilanterol (UMEC/VI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

A Study of the GSK MEK Inhibitor GSK1120212 and Everolimus in Cancer Subjects

Study To Examine The Effects Of Lapatinib On The Pharmacokinetics Of Digoxin In Subjects w/ ErbB2 Positive Breast Cancer

Fractional Flow Reserve Versus Angiography for Multivessel Evaluation (F.A.M.E.)